New Jersey-based specialty generic pharmaceutical company Teligent Inc., has acquired Alveda Pharmaceuticals Inc. for approximately $35 million. The deal gives Teligent a platform to expand its specialty generic pharmaceutical portfolio of products across Canada. “We look forward to building on the successful business that the Alveda team has created over the last several years,” said Jason Grenfell-Gardner, president and chief executive officer, Teligent. ”We see great opportunit...